For Anyone Curious About Radiesse
When researching ways to restore skin elasticity, you often come across the phrase "collagen booster." Among these, Radiesse stands out — not simply as a filler that fills empty space, but as a product whose key ingredient, Calcium Hydroxylapatite (CaHA), is reported in the literature to stimulate collagen production. Yet it can be hard to find clear, consolidated information about exactly what the ingredient is, how it works, and how long results typically last.
This guide centers on how Dr. Kim Gun-woo, Medical Director of Cellinique on Dosan-daero in Gangnam, approaches Radiesse consultations — covering CaHA's mechanism, indications, effects, duration, and safety. If you're interested in comparing Radiesse with other collagen boosters, see our Collagen Production Methods Guide or Cellinique Treatment Overview.
3-Line Summary
1. Radiesse is an injectable composed of Calcium Hydroxylapatite (CaHA) microparticles suspended in a carboxymethylcellulose (CMC) gel carrier, with a literature-reported dual action: immediate volumizing effect and stimulation of new collagen production.
2. The product holds FDA Premarket Approval (PMA P050052 and P050037) in the United States — confirmed for nasolabial folds, HIV-related facial lipoatrophy, and dorsal hand volume restoration — and is also authorized for aesthetic use in Korea (per official Merz Aesthetics Korea product information; precise MFDS license number and classification can be confirmed through official channels or during consultation).
3. Side effects such as nodules are possible, and the degree of benefit and duration of results vary considerably depending on skin condition, age, and treatment area; identical outcomes cannot be guaranteed.
1. What Is Radiesse? The Mechanism Behind a CaHA Collagen Booster
The core ingredient in Radiesse is Calcium Hydroxylapatite (CaHA) — a compound similar to the naturally occurring mineral found in bones and teeth. Radiesse consists of CaHA microparticles (approximately 25–45 µm) suspended in a carboxymethylcellulose (CMC) gel carrier.
Immediately after treatment, the CMC gel provides an instant volumizing and contouring effect. As the gel is gradually absorbed, the CaHA particles are exposed and are reported to stimulate surrounding fibroblasts to produce new collagen (primarily type III, which subsequently converts to type I). This creates a dual action: an immediate volumizing effect combined with progressive collagen stimulation over time.
💡 Fact-check ✓
Source: FDA accessdata (PMA P050052, P050037) · PMID 29391818 (Clin Cosmet Investig Dermatol, 2018) · Merz Aesthetics Korea official product information
- Radiesse: CaHA particles (25–45 µm) in a CMC gel carrier. Manufacturer: Merz Aesthetics.
- Histological evidence that CaHA stimulates fibroblasts to produce type III → type I collagen was confirmed via Picrosirius Red staining and polarized light microscopy analysis (PMID 29391818, 2018 study with tissue harvesting concurrent with abdominoplasty).
- U.S. FDA PMA approval: PMA P050037 (2006, facial lipoatrophy in HIV patients), PMA P050052 (2006, nasolabial fold wrinkles), P050052/S049 (2015, dorsal hand volume restoration). Confirmed as FDA approved (PMA).
- Domestic (Korea) authorization: "Temporary improvement of facial wrinkles in adults and restoration of dorsal hand volume" — per Merz Aesthetics Korea official product information. Precise license number and product classification can be confirmed through official MFDS channels or during consultation.
- Efficacy and duration of results vary between individuals.
CaHA is a biodegradable material that, over time, breaks down in the body into calcium and phosphate ions and is absorbed. MRI studies report that the product is fully degraded approximately 2.5 years after injection.
2. Radiesse at a Glance
| Item | Details |
|---|---|
| Ingredient category | CaHA (Calcium Hydroxylapatite, 25–45 µm) + CMC gel carrier |
| Manufacturer | Merz Aesthetics (Korea: Merz Aesthetics Korea) |
| Mechanism | Dual action: immediate volume (CMC gel) + progressive collagen stimulation (CaHA particles) |
| U.S. FDA authorization | PMA approved — P050052 (2006, nasolabial folds), P050037 (2006, HIV-related facial lipoatrophy), P050052/S049 (2015, dorsal hand volume) |
| Korea authorization | "Temporary improvement of facial wrinkles in adults and restoration of dorsal hand volume" (per Merz Aesthetics Korea official information — precise MFDS license number and classification can be confirmed through official channels or during consultation) |
| European CE | CE approved (since 2003) |
| Example treatment areas | Nasolabial folds, facial volume deficit areas, dorsal hands, neck and décolletage (diluted use, off-label) |
| Anesthesia | Topical anesthetic cream, or Radiesse Plus (formulation with lidocaine) available |
| Downtime | Temporary swelling, redness, bruising possible; varies between individuals |
| Duration (literature) | 12–18 months reported in literature; varies between individuals; cannot be guaranteed |
| Consultation & treatment | Dr. Kim Gun-woo, Medical Director — direct consultation and treatment |
※ The information above is general guidance. Suitability and outcomes vary depending on individual skin condition and health status. Whether treatment is appropriate and how it will proceed is determined through a prior consultation.
3. What Concerns Lead People to Consider Radiesse?
Radiesse is not a treatment we recommend to everyone. In consultations, it tends to be one of the options explored together when clients express concerns such as the following.
Concerns that may be relevant
- Visible facial volume loss — nasolabial folds, cheek sagging
- Declining skin elasticity with an interest in simultaneously pursuing collagen boosting
- Clients for whom HA fillers alone felt insufficient, looking for longer-lasting results with collagen stimulation
- Goals including dorsal hand volume restoration or improvement in neck and décolletage skin texture
Having these concerns does not mean Radiesse is automatically the right choice. It means it is one option worth exploring in a consultation. Whether it is truly appropriate is determined through a prior consultation and skin assessment.
Situations where we proceed with caution
- Pregnancy or breastfeeding (or if planning to become pregnant)
- Active infection or inflammation at the intended treatment site
- Current use of anticoagulants, antiplatelet agents, or immunosuppressants
- History of autoimmune disease
- Known allergy to anesthetic agents (e.g., lidocaine) or the CaHA component
- History of abnormal reactions or nodules following previous injectable treatments
If any of the above applies to you, please let us know at the time of your consultation. We will confirm whether treatment is possible and discuss alternatives.
4. How Does the Treatment Proceed?
At Cellinique, Radiesse is carried out in the following sequence. Because the design of the injection site, depth, and volume directly impacts both outcomes and safety, we maintain a careful and consistent process.
- Prior consultation + skin assessment — Dr. Kim Gun-woo personally reviews your skin condition, pattern of volume loss, treatment history, medications, and overall health. Whether Radiesse is appropriate is generally determined at this stage.
- Treatment design — The areas and depths where CaHA injection may be beneficial, along with any combination with other treatments and their sequencing, are reviewed together.
- Recovery schedule check — The timing of treatment is coordinated with your available downtime.
- Treatment — Following topical anesthesia, the product is injected at the appropriate depth. (Radiesse Plus, a formulation containing lidocaine, may also be used.)
- Aftercare guidance — Post-treatment precautions, recovery checkpoints, and the interval for any follow-up sessions are provided separately.
💡 Note — Immediately after treatment, the volumizing change from the injected gel is felt first. Over the following weeks to months, the collagen-stimulating effect of CaHA may add to the result. As recovery and the pattern of change vary between individuals, please feel free to contact Cellinique with any questions.
5. Downtime and Recovery
Radiesse, as an injectable treatment, has a recovery process. Downtime varies depending on the treatment area and volume injected, and can also differ with individual recovery capacity and lifestyle habits.
Commonly noted responses immediately after treatment
- Temporary swelling or redness at the treatment site
- Injection marks or bruising (when present, these typically resolve within a few days)
- Temporary tenderness or a sense of tightness
- A firm sensation at the injection site (this generally settles over time)
First 24 hours post-treatment
- Avoid irritating skincare products, intense heat, or vigorous facial cleansing
- Do not massage the treatment area excessively
- If you notice any changes in your condition, please contact Cellinique
First week post-treatment
- Avoid saunas, steam rooms, and strenuous exercise
- Apply sun protection thoroughly
- Reducing alcohol and smoking is advisable
Recovery differs from person to person, so discussing your recovery timeline in advance during the consultation is important.
6. Safety Profile and Side Effects
Radiesse is a medical treatment and side effects are possible. In particular, given its nature as an injectable, understanding and preparation for nodules, infection, and vascular complications is important.
💡 Fact-check ✓
Source: PMID 28247924 (J Cosmet Dermatol, 2017 — analysis of 21 studies · 5,081 treatments) · PMC11033680 (nodule treatment case)
- In an analysis of 5,081 treatments across 2,779 patients, the overall adverse event (AE) rate was approximately 3%. The most common adverse event was nodules (96%), most of which were asymptomatic or resolved spontaneously.
- Rare cases of persistent nodules, infection, and allergic reactions have been reported. Very rarely, vascular complications (visual disturbance, skin necrosis, etc.) from intravascular injection have been reported.
- A long-term follow-up study of nasolabial folds (PMID 20442101) confirmed a safe long-term profile over 3 years with no reports of nodules, granulomas, or infections.
- The occurrence and severity of side effects vary between individuals.
Commonly reported reactions
- Temporary swelling, redness, or bruising at the treatment site (most resolve within a few days)
- Mild tenderness or a nodular sensation; persistent swelling (uncommon)
- Infection, allergic reactions, persistent nodules (rare)
- Vascular complications (extremely rare; risk increases with inappropriate injection technique)
When to contact Cellinique immediately
- Severe or worsening swelling, warmth, or redness at the treatment site
- Fever or chills
- A nodule that remains firm or is growing after 2 weeks
- Sudden changes in vision or skin color (pallor or purplish discoloration)
- Allergic reactions such as hives or difficulty breathing
Information to share with us before treatment
- Pregnancy or breastfeeding status (including if planning to become pregnant)
- Current medications (especially anticoagulants, antiplatelet agents, immunosuppressants)
- Allergy history (including to anesthetic agents such as lidocaine and to CaHA)
- Active infection or autoimmune disease history
- Recent treatments received (interval and sequencing adjustments may be needed)
General safety information applicable to all treatments is available on the Cellinique Treatment Safety page.
7. Effects and Duration
Radiesse is a dual-action treatment in which an immediate volumizing effect and a progressive collagen-stimulating effect occur together. Literature often reports a duration of 12–18 months, but results vary considerably depending on individual skin condition, treatment area, and lifestyle habits, and a specific duration cannot be guaranteed.
💡 Fact-check ✓
Source: PMID 31044123 (Plast Reconstr Surg Glob Open, 2019 — expert consensus) · PMC10693750 (PMID 38050476, Clin Cosmet Investig Dermatol, 2023) · PMID 20442101 (Aesthetic Surg J, 2010)
- A biostimulation study using hyperdiluted CaHA on the face, neck, décolletage, and hands (PMC10693750) recommended a 12–18-month maintenance cycle. This was a small-scale case series and individual variation is significant.
- A long-term follow-up study of nasolabial folds (PMID 20442101) reported that 40% of subjects maintained improvement at 30+ months after the final treatment.
- An expert consensus paper (PMID 31044123) supported the use of CaHA as a biostimulator across multiple areas — face, neck, décolletage, buttocks, thighs — while noting the need for additional randomized controlled trials (RCTs).
- Efficacy and duration vary between individuals. The figures above are for reference from the literature; realistic individual expectations will be discussed in a prior consultation.
8. Radiesse vs. Other Collagen Boosters
"Which collagen booster should I choose?" is a question we often hear. Comparing products is less about which ingredient is superior and more about which mechanism matches your skin concern. The table below is general guidance for understanding the differences; individual suitability is determined in a consultation.
| Category | Radiesse (CaHA) | Juvelook (PDLLA + HA) | Rejuran (PN-based) |
|---|---|---|---|
| Key ingredient | CaHA + CMC gel | PDLLA + non-crosslinked HA | PN (polynucleotide) |
| Primary action | Immediate volume + collagen stimulation | Hydration support + collagen stimulation | Skin regeneration and repair-focused |
| Change pattern | Immediately perceptible + gradual change over weeks | Immediately perceptible + gradual change over weeks | Progressive change centered on regeneration |
| Literature duration | 12–18 months reported (individual variation) | Varies by individual; differs across literature | Varies by individual; differs across literature |
| FDA PMA approval | Approved for nasolabial folds, dorsal hands, etc. | Not FDA approved in the U.S. | Not FDA approved in the U.S. |
| Recommended interval | Varies by treatment area and individual condition; determined through consultation | ||
Ultimately, stating definitively that one treatment is superior is difficult. The first step in a consultation is finding the approach that best fits your current skin condition and goals. For a broader comparison of collagen boosters, see the Collagen Production Methods Guide.
9. How Cellinique Approaches Radiesse
Cellinique is an anti-aging focused clinic on Dosan-daero in Gangnam. For treatments like Radiesse — where the design of injection depth, volume, and site affects both outcomes and safety — consistent medical understanding and management from the treating physician is essential.
Dr. Kim Gun-woo, Medical Director, draws on his training and case experience in CaHA collagen booster treatments to personally oversee the process from initial consultation through treatment and follow-up assessment. The clinic's location on Dosan-daero also makes return visits and progress checks more convenient — a practical advantage for treatments like this, where collagen-stimulated changes are assessed over time together with the patient.
Frequently Asked Questions (FAQ)
Q1. How is Radiesse different from a regular filler?
A standard HA (hyaluronic acid) filler fills volume immediately after injection and its effect diminishes as the HA is absorbed. Radiesse (CaHA) has a literature-reported dual action: immediate volumizing along with CaHA particles stimulating fibroblasts to induce collagen production. Suitability and the treatment approach are determined in a prior consultation.
Q2. Has Radiesse received FDA approval?
Yes. Radiesse has received FDA Premarket Approval (PMA). Approvals confirmed: PMA P050052 (2006, nasolabial fold wrinkles), PMA P050037 (2006, HIV-related facial lipoatrophy), and P050052/S049 (2015, dorsal hand volume restoration). These can be verified on the FDA accessdata database (accessdata.fda.gov).
Q3. When can I expect to see results?
Immediately after treatment, the volumizing and contouring change from the CMC gel is felt first. Over the following weeks to months, the collagen-stimulating effect of CaHA may add to the result. However, the timing and extent of perceived change varies considerably between individuals depending on skin condition, age, and treatment area, and identical results cannot be guaranteed.
Q4. How long do results last?
Literature frequently reports durations of 12–18 months, and a long-term nasolabial fold study reported that some patients maintained improvement beyond 30 months (PMID 20442101). However, results vary considerably depending on individual skin condition, lifestyle habits, and treatment area, and a specific duration cannot be guaranteed. Realistic expectations for your individual case will be discussed in a consultation.
Q5. Are nodules inevitable?
Nodules are the most commonly reported side effect of CaHA-based treatments. In a literature review (PMID 28247924), adverse events were reported in approximately 3% of 5,081 treatments, with nodules accounting for 96% of those events. Most are asymptomatic or resolve on their own, but persistent nodules can occasionally occur. The injection site and technique are known to influence nodule occurrence; Cellinique approaches treatment site design with care.
Q6. How is Radiesse different from Juvelook?
The core ingredients and mechanisms differ. Radiesse uses CaHA + CMC gel, targeting both immediate volume and collagen stimulation simultaneously. Juvelook is a skin booster using PDLLA + non-crosslinked HA, combining hydration support with collagen stimulation. Both include collagen stimulation, but they differ in ingredient profile and the degree of volumizing effect. Which is more suited to your concern is determined in a consultation.
Q7. What are the side effects and precautions?
Temporary swelling, redness, and bruising are possible, as are occasional nodules and tenderness. Very rarely, infection and allergic reactions have been reported. Vascular complications (e.g., visual disturbance) from intravascular injection are extremely rare but have been reported, making it important that the treatment is performed by an experienced physician. Please inform us in your consultation if you have a history of pregnancy or breastfeeding, active infection, anticoagulant use, autoimmune disease, or allergies to any of the ingredients.
Q8. Can I come in just for a consultation?
Of course. Because Radiesse involves design decisions around the area, goals, and sequencing relative to other treatments, we encourage you to fully understand your options before deciding. Regardless of whether treatment proceeds, please feel free to reach us at 02-6203-3434 or via KakaoTalk. (Consultation and treatment fees vary depending on your individual condition and treatment design, and will be discussed during the consultation.)
Closing
Radiesse is not a treatment to choose simply because it's well known. What matters most is confirming whether CaHA's dual action of immediate volume and collagen stimulation genuinely matches your skin concern and goals. Starting treatment with a clear understanding of the potential side effects and individual variability is the informed choice.
At Cellinique on Dosan-daero in Gangnam, Dr. Kim Gun-woo personally oversees everything from the initial consultation through treatment and follow-up assessment. If you are considering Radiesse, we invite you to begin with a consultation — a conversation about your skin condition and goals in a comfortable, no-pressure setting. For a broader comparison of collagen boosters, see our Collagen Production Methods Guide; for treatment details, visit our Cellinique Treatment Overview; and for shared safety standards, our Treatment Safety page.
Efficacy and duration of results vary depending on individual skin condition, age, and lifestyle patterns, and identical results cannot be guaranteed.
Treatment carries the possibility of temporary side effects such as erythema, swelling, and nodules; contraindications may also apply. These will be reviewed in a prior consultation.
✅ Fact-check Report
The principal medical information in this article was confirmed against the following sources.
- FDA accessdata — PMA P050052 / P050037 — Radiesse PMA approvals (2006: nasolabial folds and HIV-related facial lipoatrophy; 2015: dorsal hand volume). "FDA approved (PMA)" designation is accurate.
- Merz Aesthetics Korea official product information — Domestic indication confirmed as "temporary improvement of facial wrinkles in adults and restoration of dorsal hand volume." Precise license number and classification can be confirmed through official MFDS channels or during consultation.
- PMID 29391818 (Clin Cosmet Investig Dermatol, 2018) — Histological evidence of CaHA-induced type III → type I collagen production confirmed.
- PMID 28247924 (J Cosmet Dermatol, 2017) — CaHA safety review: 21 studies, 5,081 treatments; overall AE rate 3%; nodules most common adverse event at 96%.
- PMID 20442101 (Aesthetic Surg J, 2010) — Long-term follow-up of nasolabial folds over 39 months; 40% maintained improvement beyond 30 months; no nodules or granulomas reported.
- PMID 38050476 / PMC10693750 (Clin Cosmet Investig Dermatol, 2023) — Hyperdiluted CaHA biostimulation: 12–18-month maintenance cycle recommended (small-scale case series).
- PMID 31044123 (Plast Reconstr Surg Glob Open, 2019) — Expert consensus: supports CaHA biostimulator use across face, neck, décolletage, and body; notes need for additional RCTs.
- Precise Radiesse product license number, classification, and indication text can be confirmed through official MFDS channels or during consultation. For hyperdiluted and off-label use areas (neck, décolletage), please discuss domestic authorization scope with your physician.
Medical Disclaimer
This content is provided for general health information purposes only. For diagnosis and treatment tailored to your individual circumstances, please consult a qualified physician.
Cellinique — Consultation & Appointments
228 Dosan-daero, Gangnam-gu, Seoul (Yeonseung Building)
Tel: 02-6203-3434
Hours: Mon–Fri 10:00–19:00 / Last Saturday of each month 10:00–16:30
